Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2022 - 11 - 03 save search
Pyxus International, Inc. to Announce Second Quarter Fiscal Year 2023 Financial Results on November 10, 2022
Published: 2022-11-03 (Crawled : 22:00) - prnewswire.com
PYYX | $3.0 10.8% 4K
|
Retail Trade
|
| O: 172.73%
H: 130.0%
C: 66.67%
year financial results
Virax Biolabs Introduces RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit
Published: 2022-11-03 (Crawled : 12:00) - prnewswire.com
VRAX | $0.644 -5.25% -5.54% 8.2K
|
n/a
|
| O: 49.4%
H: 1.59%
C: -8.76%
test rapid virus
NeuroMetrix Announces Strategic Launch of Quell Fibromyalgia
Published: 2022-11-03 (Crawled : 13:00) - globenewswire.com
NURO | $4.28 17.26% 14.72% 250K
|
Health Technology
|
| O: 26.11%
H: 5.05%
C: -28.79%
fibromyalgia quell
Acutus Medical Achieves OEM Qualification Milestone in Sale of Left-Heart Access Portfolio to Medtronic
Published: 2022-11-03 (Crawled : 13:00) - globenewswire.com
AFIB | $0.167 -4.3% -4.49% 400K
|
Health Technology
|
| O: 25.7%
H: 17.05%
C: 11.15%
milestone
Creative Medical Technology Holdings Announces FDA Clearance of Investigational New Drug (IND) Application for AlloStem™, a Novel Cell Therapy for the Treatment of Type 1 Diabetes
Published: 2022-11-03 (Crawled : 12:20) - biospace.com/
CELZ | $4.82 0.21% 0.21% 22K
|
|
| O: 19.85%
H: 41.67%
C: 4.17%
treatment fda clearance drug application technology diabetes therapy
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR SECOND QUARTER ENDED September 30, 2022
Published: 2022-11-03 (Crawled : 20:00) - globenewswire.com
PETV P | $0.72 -2.15% 18K
|
Manufacturing
|
| O: 19.09%
H: 0.0%
C: -7.6%
Huadi International Group Co., Ltd. Announces Strategic Plan to Enter New Energy Industry, Initiates Discussion with a Sichuan Local Government to Invest and Construct New Energy Battery and Storage Project
Published: 2022-11-03 (Crawled : 13:00) - globenewswire.com
HUDI | $2.5 -3.48% -3.6% 26K
|
|
| O: 14.2%
H: 269.11%
C: 200.17%
battery energy international group
DoorDash Releases Third Quarter 2022 Financial Results
Published: 2022-11-03 (Crawled : 21:00) - prnewswire.com
DASH 4 | $127.23 -2.21% -2.26% 4.6M
|
Retail Trade
|
| O: 13.88%
H: 5.09%
C: -4.89%
financial results
Tecnoglass Reports Record Third Quarter 2022 Results and Announces $50 Million Share Repurchase Program
Published: 2022-11-03 (Crawled : 11:00) - globenewswire.com
TGLS | $54.71 -3.24% 0.0% 420K
|
Producer Manufacturing
|
| O: 13.57%
H: 8.05%
C: 4.56%
repurchase program results
TASEKO REPORTS IMPROVED PRODUCTION AND $34 MILLION OF ADJUSTED EBITDA* FOR THIRD QUARTER 2022
Published: 2022-11-03 (Crawled : 23:00) - prnewswire.com
TGB | $2.46 -1.21% 0.0% 2.5M
|
Non-Energy Minerals
|
| O: 12.15%
H: 6.67%
C: 3.33%
When the Going Gets Tough…
Published: 2022-11-03 (Crawled : 15:00) - infinera.com
INFN | News | $4.715 1.18% 1.17% 2.3M
|
Electronic Technology
|
| O: 11.66%
H: 8.39%
C: 7.02%
Affimed Announces Presentation of Phase 1/2 Data from AFM13 in Combination with Allogeneic NK Cells and Preclinical AFM28 Data at ASH 2022 Annual Meeting
Published: 2022-11-03 (Crawled : 13:00) - globenewswire.com
AFMD | $5.15 1.58% 1.55% 64K
|
Health Technology
|
| O: 11.24%
H: 15.69%
C: -1.6%
afm13 preclinical meeting afm28 presentation phase 1
Affimed and Artiva Biotherapeutics Announce Partnership to Advance Combination Therapy of Innate Cell Engager (ICE®) AFM13 and Off-the-Shelf Allogeneic NK Cell Therapy AB-101
Published: 2022-11-03 (Crawled : 13:20) - globenewswire.com
AFMD | $5.15 1.58% 1.55% 64K
|
Health Technology
|
| O: 11.24%
H: 15.69%
C: -1.6%
afm13 ice partnership ab-101 therapy
Bruker Reports Third Quarter 2022 Financial Results
Published: 2022-11-03 (Crawled : 12:00) - biospace.com/
BRKR | $77.725 -1.06% -1.07% 1.3M
|
Health Technology
|
| O: 11.17%
H: 0.0%
C: -5.45%
financial results
Inozyme Pharma Announces First Self-Administration of INZ-701 in Ongoing ENPP1 Deficiency Phase 1/2 Clinical Trial
Published: 2022-11-03 (Crawled : 12:20) - biospace.com/
INZY | $4.5 -1.75% -1.78% 590K
|
Health Technology
|
| O: 10.53%
H: 3.91%
C: -4.17%
inz-701 ongoing pharma trial phase 1
Reaction Biology and Vyant Bio Announce Closing of Definitive Agreement to Acquire U.S. Operations of Vyant Bio, Inc. Subsidiary
Published: 2022-11-03 (Crawled : 13:00) - globenewswire.com
VYNT | $0.194 -8.51% 19K
|
Health Care and Social Assistan...
|
| O: 10.53%
H: 7.14%
C: -16.14%
acquire agreement
Amplitude’s Response to the OpenSSL Vulnerability
Published: 2022-11-03 (Crawled : 21:00) - amplitude.com
AMPL | $9.48 0.21% 0.21% 300K
|
|
| O: 10.22%
H: 6.31%
C: -12.26%
response
IDEX Biometrics and UK issuer to launch biometric payment cards in Europe
Published: 2022-11-03 (Crawled : 08:00) - idexbiometrics.com
IDBA | $4.88 1.67% 0.0% 9
|
Manufacturing
|
| O: 10.21%
H: 0.0%
C: 0.0%
europe payment
PEABODY REPORTS RESULTS FOR QUARTER ENDED SEPTEMBER 30, 2022
Published: 2022-11-03 (Crawled : 12:20) - prnewswire.com
BTU | $24.08 -0.04% 0.0% 1.4M
|
Energy Minerals
|
| O: 9.43%
H: 8.74%
C: -6.18%
MasTec Announces Third Quarter 2022 Financial Results with Record Backlog and Updated Annual 2022 Guidance
Published: 2022-11-03 (Crawled : 22:00) - prnewswire.com
MTZ | $84.42 1.17% -1.58% 680K
|
Industrial Services
|
| O: 9.36%
H: 7.93%
C: 7.13%
financial results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.